WO1981002790A1 - New solid supports for proteins for analytical purposes - Google Patents
New solid supports for proteins for analytical purposes Download PDFInfo
- Publication number
- WO1981002790A1 WO1981002790A1 PCT/EP1980/000018 EP8000018W WO8102790A1 WO 1981002790 A1 WO1981002790 A1 WO 1981002790A1 EP 8000018 W EP8000018 W EP 8000018W WO 8102790 A1 WO8102790 A1 WO 8102790A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteins
- nitrocellulose
- sheet
- nitrocellulose sheet
- anyone
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 151
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 151
- 239000007787 solid Substances 0.000 title claims abstract description 15
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 110
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 110
- 238000000034 method Methods 0.000 claims abstract description 65
- 238000001962 electrophoresis Methods 0.000 claims abstract description 46
- 238000003018 immunoassay Methods 0.000 claims abstract description 17
- 230000008569 process Effects 0.000 claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 7
- 108090000790 Enzymes Proteins 0.000 claims abstract description 7
- 230000005684 electric field Effects 0.000 claims abstract description 7
- 239000000499 gel Substances 0.000 claims description 88
- 238000012546 transfer Methods 0.000 claims description 30
- 210000002966 serum Anatomy 0.000 claims description 21
- 239000003599 detergent Substances 0.000 claims description 18
- 239000000427 antigen Substances 0.000 claims description 16
- 108091007433 antigens Proteins 0.000 claims description 16
- 102000036639 antigens Human genes 0.000 claims description 16
- 239000002504 physiological saline solution Substances 0.000 claims description 15
- 229920002678 cellulose Polymers 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 11
- 238000001179 sorption measurement Methods 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 9
- 229920002401 polyacrylamide Polymers 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical group O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- 238000011534 incubation Methods 0.000 claims description 5
- 229910017604 nitric acid Inorganic materials 0.000 claims description 5
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 108010058683 Immobilized Proteins Proteins 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 238000000376 autoradiography Methods 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- -1 nitric acid ester Chemical class 0.000 claims description 4
- 230000001575 pathological effect Effects 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 3
- 108090001030 Lipoproteins Proteins 0.000 claims description 3
- 102000004895 Lipoproteins Human genes 0.000 claims description 3
- 108010085220 Multiprotein Complexes Proteins 0.000 claims description 3
- 102000007474 Multiprotein Complexes Human genes 0.000 claims description 3
- 229920002301 cellulose acetate Polymers 0.000 claims description 3
- 208000023275 Autoimmune disease Diseases 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 229940027941 immunoglobulin g Drugs 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000009738 saturating Methods 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 239000003269 fluorescent indicator Substances 0.000 claims 1
- 238000013508 migration Methods 0.000 abstract description 6
- 230000005012 migration Effects 0.000 abstract description 6
- 238000000926 separation method Methods 0.000 abstract description 5
- 235000018102 proteins Nutrition 0.000 description 117
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 229940098773 bovine serum albumin Drugs 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 238000009792 diffusion process Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 102000018358 immunoglobulin Human genes 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000003705 ribosome Anatomy 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 102000002278 Ribosomal Proteins Human genes 0.000 description 5
- 108010000605 Ribosomal Proteins Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 241000283707 Capra Species 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 4
- 239000004327 boric acid Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 102000013415 peroxidase activity proteins Human genes 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 3
- 229940043264 dodecyl sulfate Drugs 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 229940072221 immunoglobulins Drugs 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VUPXKQHLZATXTR-UHFFFAOYSA-N 2,4-diphenyl-1,3-oxazole Chemical compound C=1OC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 VUPXKQHLZATXTR-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 2
- 101800000263 Acidic protein Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000026045 iodination Effects 0.000 description 2
- 238000006192 iodination reaction Methods 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 210000004708 ribosome subunit Anatomy 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- CNRNYORZJGVOSY-UHFFFAOYSA-N 2,5-diphenyl-1,3-oxazole Chemical compound C=1N=C(C=2C=CC=CC=2)OC=1C1=CC=CC=C1 CNRNYORZJGVOSY-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 108091008885 GPCRs class E Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000005717 Myeloma Proteins Human genes 0.000 description 1
- 108010045503 Myeloma Proteins Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000000211 autoradiogram Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 229940098197 human immunoglobulin g Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000000521 hyperimmunizing effect Effects 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940066827 pertussis vaccine Drugs 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006485 reductive methylation reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/4473—Arrangements for investigating the separated zones, e.g. localising zones by electric means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
Definitions
- the present invention concerns new solid supports for proteins for analytical purposes, a process for their preparation, and their use, especially as diagnostic tools.
- the invention is directed to porous nitrocellulose sheets containing a replica of an electropherogram of proteins in a gel.
- the form in which the proteins are immobilized on the nitrocellulose sheet is excellentlysuitable for analytical purposes, such as the detection and identification of proteins by solid state immuno-assay methods, such as those currently used, for instance radioactive methods, fluorometric methods or enzyme immuno-assays.
- the invention thus comprises also the use of the r ⁇ ew solid supports for proteins for the immuno detection of proteins, antigens and antibodies, especially as diagnostic tools.
- the invention is chiefly based on the finding that it is possible to transfer proteins from a gel (as currently used in protein biochemistry, eg a gel used for the electrophoretic separation of proteins) on to sheets of nitrocellulose, that is to say on cellulose nitric acid ester supports in the form of thin sheets, which may contain in addition other cellulose esters, such as cellulose acetate.
- the transfer of the proteins to the gel can be quantitative, and the immobilized proteins form an exact replica of the pattern which was present in the gel.
- Polyacrylamide gel electrophoresis has become a standard tool in every laboratory in which proteins are analyzed and purified. Most frequently, the amovmt and location of the protein are of interest and staining is then sufficient.
- Enzymatic and binding actxvities can sometimes be detected in situ by letting substrates or ligands diffuse into the gel.
- the antigen In immunoelectrophoresis, the antigen is allowed to diffuse or electrophoretically move against antibody. A precipitate is then formed where the antigen and antibody interact. Modifications have been described in which the antigen is precipitated by directly soaking the separation matrix in antiserum.
- the choice of electrophoretic systems is then severely limited by the need to have a gel of sufficiently large pore size as to permit the diffusion of the antibody and / or antigen. Such systems are also dependent on concentration and type of antigen or antibody to give a physically immobile aggregate. Attempts have therefore been made to transfer the proteins isolated in gels on to solid supports, as will be described below.
- the transfer of the proteins from the gel to the nitrocellulose support is carried out, according to the present invention, by an electric field applied to the gel containing the proteins, causing an electrophoretic migration of the latter, for instance previously separated by some standard electrophoresis procedure, and in the form of an electropherogram.
- the electric field is applied so that the proteins will migrate in the direction of the nitrocellulose sheet which is in contact with the gel, preferably perpendicular to the plane of the gel.
- the immobilized proteins on the nitrocellulose sheet are stable against washing the sheet, for instance against treatment with suitable salt solutions, for instance saline (physiological sodium chloride solution).
- the sheets shall be treated with appropriate proteins which will saturate the residual adsorption capacities of the nitrocellulose sheet. This is done by saturating the sheet with an individual non-specific protein, or with a mixture of such proteins, or with total serum, or any combination of these ingredients, alone and / or together with the ingredient of the subsequent immuno-assay steps .
- appropriate proteins which will saturate the residual adsorption capacities of the nitrocellulose sheet. This is done by saturating the sheet with an individual non-specific protein, or with a mixture of such proteins, or with total serum, or any combination of these ingredients, alone and / or together with the ingredient of the subsequent immuno-assay steps .
- the only limitation, as described below, is that these should not interfere with or crossreact with any of the specific antibodies in the immuno-assay.
- this electropherogram is transferred on to a nitrocellulose sheet by contacting the gel with a nitrocellulose sheet and this transfer is achieved by electrophoresis, and, if desired, all residual adsorption capacities of the sheet for proteins are saturated by incubation with an appropriate medium containing proteins capable of being adsorbed by nitrocellulose.
- the transfer of the proteins to the nitrocellulose is achieved by electrophoresis perpendicular to the plane of the assembly consisting of the nitrocellulose sheet superposed to the gel.
- protein as used in this application there are to be understood proteins as such and also naturally occurring protein conjugates, such as glycoproteins, lipoproteins or protein-nucleic acid complexes.
- protein conjugates such as glycoproteins, lipoproteins or protein-nucleic acid complexes.
- the transfer of electropherograms from gels to nitrocellulose sheets. has already been described in the case of DNA [Southern, EM (1975) J. Mol. Biol. 98, 503-517].
- immobilization of the gel pattern of DNA onto the nitrocellulose was achxeved passively, without electrophoresis. Analysis of protein produced by bacterial colonies on agar plates has been performed by adsorption to antibody coated plastic sheets [Broome S, Gilbert W., (1978), Proc. Natl. Acad. Be.
- Nitrocellulose sheets have also been used for the adsorption of immunoglobulins selected from hybridoma colonies growing in a gel [Sharon J., Morrison SI & Kabat EA, (1979) Proc. Natl. Acad. Be. USA, 76, 1420-1424]. Neither of these methods deals with electrophoretically transferred proteins, and, as described, they are not designed to deal with an unlimited number of individual antigen-antibody reactions simultaneously, as the method of the present invention does.
- Renart et al [Proc. Nat. Acad. Sci. US 76, 3116, 17979] use a modified polyacrylamide gel system which can be chemically disrupted in order to increase the rate of transfer also by diffusion of the proteins, as opposed to the electrophoretic system of the present invention. They also used a modified cellulose which has reactive groups attached and covalently binds proteins. This modified cellulose has the disadvantage of needing to be prepared immediately before use, requiring three steps of chemical treatment of the paper and an organic synthesis of a compound which is not readily available. Their procedure is therefore cumbersome to set up in practice.
- the electrophoretic transfer of the proteins from the gel to the nitrocellulose sheet according to the present invention is by its simplicity and versatility a decisive step forward in the analysis of proteins. This is because resolution of the original electropherogram is conserved and the recovery of proteins is usually high. Further if is usually difficult to prepare dried polyacrylamide gels for autoradiography because of the tendency to split and crack during drying. The drying of the nitrocellulose sheets is trivial, requiring only a hair dryer or other source of warm air. Because the proteins become concentrated on a very thin layer, autoradxography from 14 C- and 35 -Slabeled proteins should be highly efficient even without 2,5-diphenyloxazole impregnation. Tritiated proteins immobilized on the nitrocellulose sheets can be processed for fluorography by brief soaking in 10% diphenyloxazole in ether.
- nitrocellulose as referred to the solid supports of the present invention are understood nitric acid esters of cellulose, if desired, in mixture with other cellulose esters.
- pure nitrocellulose can be used as consisting of an ester of cellulose having approximately 3 nitric groups per 6 atoms.
- nitric acid esters with less than such number of groups can be used.
- these latter can be any acids normally used for making cellulose esters, preferably aliphatic acids having from 1 to 7 C atoms, such as acetic acid, propionic acid, the butyric or valerianic acids.
- a "nitrocellulose” known in commerce under the name of "Millipore” (commercialized by the firm Millipore, Bedford, Mass. USA) having a pore size of 0.45 micron, and which represents a mixed ester of nitric acid and cellulose acetate.
- the pore size of the cellulose esters to be used may vary within wide limits, preferably between a size of 0.025 and 14 micron.
- the sheets may have dimensions typically of 12x14 cm, corresponding to the most commonly used slab gel electrophoresis system [Howard, G.A. & Traut, R.R., 1973, FEBS Letters 29, 177-180], but may rmonye from, for example, the micro System (50x75 mm) using microscope slides [Linz, A., Collatz E. O., Wool, I.G., Molec. Gen. Genet (1976) 144, 1-9] to the original macro (20x20 cm) system [Kaltschmid, E., Wittmann, H.G. (1970) Proc. Nat. Acad. Sci. US 67, 1276-1280].
- the gel slab thickness can rmony preferably from 0.8 to 5 mm.
- the electropherograms to be transferred to the nitrocellulose sheets may have been obtained in various gel media, such as agarose, agar, and especially polyacrylamide.
- various gel media such as agarose, agar, and especially polyacrylamide.
- protein denaturing agents such as, eg anionic detergents, especially esters of higher aliphatic alcohols having between 8 and 20 C atoms, primarily with sodium dodecyl sulfate.
- protein denaturing agent there is also especially used urea.
- the nature of the individual proteins denaturing agent and buffer used in the transfer determines the direction of the electric field to be applied in the electrophoresis.
- the proteins will always migrate toward the anode.
- the migration direction of the proteins in a given substrates can be determined by placing nitrocellulose sheets on both sides of the gel electropherogram.
- the electropherograms obtained in the gel slabs commonly used in the electrophoretic separation of proteins may be one dimensional or two dimensional, as obtained by known techniques.
- the transfer of the electropherograms on to the nitrocellulose sheets can be made according to any suitable technique which uses in principle an electrophoretic chamber in which the gel slab is introduced, containing a suitable medium, and the nitrocellulose sheet is applied on that side of the slab where the proteins will migrate.
- a preferred assembly for such transfer consists of: a scouring pad known as Scotch Brite 96 (3M) whi ch is supported by a stiff plastic grid (disposable micropipette tray, Medical Laboratory, Inc., New York); a second pad and plastic grid, opposed to the first, contains the gel slab with the nitrocellulose sheet kept evenly and firmly pressed on it by rubber bands strung around both pads.
- a scouring pad known as Scotch Brite 96 (3M) whi ch is supported by a stiff plastic grid (disposable micropipette tray, Medical Laboratory, Inc., New York); a second pad and plastic grid, opposed to the first, contains the gel slab with the nitrocellulose sheet kept evenly and firmly pressed on it by rubber bands strung around both pads.
- the transfer medium shall be dilute acid to ensure that the pH is below the isoelectric points of all proteins.
- dilute acetic acid is usually used.
- the proteins will then migrate toward the cathbde.
- a slightly alkaline pH of about 7.5- to about 10 is appropriate to maintain the detergent protein complexes and the anodal migration.
- a pH of about 8.5 is optimal e.g. when dodecyl sulfate is used as detergent.
- the sheets of nitrocellulose containing the exact replica of the electropherogram in the gel may be used, inter alia, for various types of immuno assays.
- the present invention thus comprises also the use of the solid supports in the form of the nitrocellulose sheets containing the immobilized proteins for the immuno detection of proteins, antigens and antibodies, and the solid nitrocellulose supports therefore represent new diagnostics tools.
- the proteins transferred on to the nitrocellulose sheet ⁇ ay be from any source: animals, plants, bacteria, viruses, and may be any known naturally occurring protein conjugates such as glycoproteins and lipoproteins, and may also be protein-nucleic acid complexes such as ribosomes or nuclear ribonucleoprotein complexes.
- the class of viral and bacterial protexns are pathogens and animal proteins and protein complexes causing auto-immune disease.
- proteins can be located in the sheets by a staining procedure.
- the proteins can be stained on the nitrocellulose sheet, for instance using amido black, and excess stain removed, for instance using methanol / acetic acid / water.
- the residual binding capacities of the nitrocellulose sheets have to be saturated by treatment with one or more types of proteins different from those immobilized and not cross-reacting with any of the antibodies subsequently used. This can be achieved directly after the transfer has been made.
- the residual binding sites of the nitrocellulose sheet are saturated by treatment with non-specific proteins, for instance bovine serum albumin.
- non-specific proteins for instance bovine serum albumin.
- Such proteins are diluted in physiological saline, and the nitrocellulose sheet is incubated with this solution, preferably at slightly elevated temperature, for instance between about 30 ° and 50 °, preferably at about 40 °, andwashed with physiological saline.
- the preferred conditions for carrying out these steps are with concentrations of 3% (weight / volume) of bovine serum albumin as non-specific protein and 10% (volume / volume) of the carrier serum, all diluted in physiological saline.
- the treatments with the non-specific protein and serum used as carrier might be carried out separately rather than in combination with the treatments with anti-serum and indicator antibody.
- the immuno assay with the antiserum to be analyzed can be made by incubation with such serum diluted according to the expected antibody concentration, usually in the range 1:10 to 1: 1000 in physiological saline, for instance in the range of 2 hours to overnight , at room temperature, and then washed extensively with physiological saline.
- the indicator antibody is radioactively labeled, or conjugated with a fluorescent substance, or with an enzyme capable of giving a color reaction with its substrates.
- the indicator antibody is usually diluted about 50-fold in a mixture of the above named first non-specific protein and the carrier serum, incubated 30 minutes, and washed again in physiological saline.
- immunoglobulin can be used in autoradiography, immunoglobulin conjugated with fluorescein for the fluorometric method or with horseradish peroxidase for the enzyme immune method, with the use of o-dianisidine in the presence of hydrogen peroxide, as the substrate for the peroxidase for eliciting a color reaction, in the case of the horseradish peroxidase method, with the colored reaction product being insoluble and remaining immobilized at the site of formation.
- the presence of such proteins in solution in an unknown sample can be determined by its ability to compete with the antibody reaction on the solid support, by well known procedures.
- the known proteins for instance transferred from a one dimensional electropherogram in a gel, can also be separated by cutting the sheet into various strips corresponding to each isolated protein, or parallel replica Strips containing all separated proteins, and with such strips various individual sera containing unknown antibodies can be easily screened.
- the method is very sensitive, and small amounts of electrophoretically separated antigen, as well as small amounts of antibody in a serum of low titer, can be detected.
- the peroxidase procedure has the additional merit of simplicity and permitting direct visualization with no special instrumentation. Because the antigen is immobilized on a sheet, the antibody is not required to form a precipitate with the antigen.
- the blotting technique therefore has the potential for immunoelectrophoretic analysis of proteins by using binding of monovalent immunoglobulin fragments or binding of antibodies directed against a single determinant, such as monoclonal antibodies produced by hybridomas. This could not be done by current immunoelectrophoretic techniques.
- hybridoma clones are obtained from a mouse immunized with impure immunogen, it is possible to use the technique to screen for clones making antibody directed against a desired antigen.
- the desired antigen has a characteristic mobility in polyacrylamide gel electrophoresis the appropriate clone can be selected without ever having pure antigen.
- the procedure of immuno assays according to the present invention also has a potential as a tool for screening pathological sera containing auto-antibodies- eg those against ribosomes or other nucleoprotein complexes.
- the precxse identification of the immunogenic components may be a useful diagnostic tool for various pathological conditions.
- a further advantage of immobilization of proteins on nitrocellulose is the ease of processing for autoradiography.
- Conventional staining, destaining, and drying of polyacrylamide gels takes many hours, and the exact drying conditions are extremely critical, especially for 18% gels as used in the second dimension for ribosomal proteins.
- the electrophoretic blotting takes 1 hour, staining and destaining less than 10 minutes, and drying an additional 5 minutes. This is thus both faster and simpler than conventional procedures, and it eliminates the tedious and hazardous procedure of soaking the gels in diphenyloxazole.
- the technique is applicable to any analytical procedure depending on formation of a protein ligand complex.
- the usual procedure of forming a complex in solution and retaining it on a membrane would have to be reversed: the protein, already adsorbed to the membrane, would have to retain the ligand from a solution into which the membrane is immersed .
- Interactions that can possibly be analyzed in this way include hormone-receptor, cyclic AMP-receptor, and protein-nucleic acid interactions.
- the ligand may also be a protein. Enzymes separated on polyacrylamide gels could also be conveniently localized on blots by in situ assays.
- a critical requirement for these applications is that the protein is not damaged by the adsorption process and that binding sites remain accessible to ligands and substrates.
- considerations similar to those in affinity chromatography and insoluble enzyme techniques pertain.
- the method can also be adapted to the procedure for the analysis of proteins eluted from bands in polyacrylamide gels by one-dimensional fingerprints [Cleveland et al (1977), J. Biol. Chem. 252, 1102-1106]: one could label by iodination in situ on the nitrocellulose, and then carry out the proteolytic digestion.
- Example 1 Escherichia coli ribosomal L7 and L12 are extracted by the method described in "Hamel, E., Koka, M. & Nakamoto, T, (1972) Biol. Chem. 247, 805-814” from 50S ribosomal subunits and purified as described in "Möller, W., Groene, A., Terhorst, C. & Amons, R. (1972) Eur. J. Biochem. 25, 5-12” by ion exchange chromatography on carboxymethyl and DEAE cellulose . Antibodies are raised in a goat by injecting 250 ⁇ g of protein emulsified with complete Freund's adjuvant intracutaneously distributed over several sites.
- Bacillus pertussis vaccine (1., 5 ml) of Bordet-Gengou vaccine (Swiss Serum and Vaccine Institute, Bern, Switzerland) is given subcutaneously with every antigen injection.
- Booster injections of the same formulation are given on days 38, 79 and 110. The animal is bled on day 117 and the antiserum to be analyzed is taken from the jugular vein.
- a mixture of Escherichia coli total ribosomal proteins is subjected to electrophoresis in two dimensions as follows:
- the separating gel (8 M urea; 8% acrylamide; 0.021 M EDTA; 0.5 M boric acid; 0.4 M Tris; 0.3% N, N, N ', N'-tetramethylethylenediamine, 0.3% N, N'-methylenebisacrylamide, pH 8.6 ; 3 ul / ml of gel solution of 10% ammonium persulfate) with migration in the direction df the anode has. a length of 5 cm and the gel with migration towards the cathode a length of 7.5 cm.
- a 5-mm stacking gel (8 murea; 4% acrylamide; 0.2% N, N'-methylenebisacrylamide; 0.002 M EDTA; 0.005 M boric acid; 0.06% N, N, N ', N'-tetramethylethylenediamine, pH 8.6; 20 ⁇ l / ml of gel solution of 0.5 mg / ml of riboflavin, 5 mg / mm of ammonium persulfate) is layered on top of the separating gel. In some cases, the length of the gel is increased to 10 cm in order to visualize possible faster migrating proteins.
- the lower electrode buffer is 0.0064 M EDTA; 0.155 M boric acid; 0.12 M Tris; pH is adjusted to 8.6 with 10 M NaOH.
- Prior to use the gel tubes are coated with 1% v / v dimethyldichlorosilane in toluene and allowed to dry at room temperature. The sample of c. 100 ⁇ g of total E.
- coli ribosomal protein is dissolved in 40 ⁇ l to 50 ⁇ l of sample buffer (8 M urea; 0.002 M Na.EDTA; 0.005 M boric acid; 0.06% N, N, N ', N'-tetramethylethylenediamine; 0.04% 2-mercaptoethanol; pH 8.6), with 5 ⁇ l of 0.05% bromphenol blue (acidic proteins) or 0.1% pyronin G (basic proteins) in 20% glycerol added as tracking dye and heated to 40 ° for 20 minutes. After cooling to room temperature, the sample solution is layered on to the stacking gel and carefully overlayered with reservoir buffer.
- sample buffer 8 M urea; 0.002 M Na.EDTA; 0.005 M boric acid; 0.06% N, N, N ', N'-tetramethylethylenediamine; 0.04% 2-mercaptoethanol; pH 8.6
- bromphenol blue acidic proteins
- pyronin G basic proteins
- Stacking is 100 V for 15 minutes, and electrophoresis in the direction of the anode is continued at 175 V, and towards the cathode at 275 V for a total of 5 hours.
- Gels are removed from the tubes with a fine needle and syringe by gently injecting 10% glycerol between the gel and tube wall. After removal, the gels are soaked in 0.3 N HC1 for 5 minutes and placed into second-dimension gel solution for 10 minutes.
- the second-dimensional gel is as described by Howard, G.A. & Traut, R.R. (1973), FEBS LETTERS 29, 177-180, except that the amount of N, N'-methylenebisacrylamide is 0.38% w / v. Electrophoresis is at a constant 105 V for 14 hours. The dimensions of the slab are 11x14 cm and it is 2 mm thick.
- the proteins are then transferred to the nitrocellulose sheets as described in the general part, using Millipore sheets in roll form of pore size 0.45 ⁇ m.
- the sheet is briefly wetted with water and put on to the pad as described.
- the gel used for electrophoresis is put on the nitrocellulose sheet and care is taken to remove all air bubbles.
- the second pad and plastic grid are added and rubber bands are strung around all layers.
- the gel is thus firmly and evenly pressed against the nitrocellulose sheet.
- the assembly is put into an electrophoretic destaining chamber with the nitrocellulose sheet facing the cathode.
- the chamber contains 0.7% acetic acid.
- a voltage gradient of 6V / cm is applied for one hour.
- the transfer of proteins to the nitrocellulose is quantitative as evidenced by lack of detectable protein in the original gel.
- the electrophoretic blots are soaked in 3% bovine serum albumin in physiological saline (0.9% NaCl / 10mM Tris-HCl, pH 7.4) for one hour at 40 ° C to saturate additional protein binding sites. They are rinsed in saline and incubated with 5 ml of the following: the goat antiserum obtained above having a titer of 340 pmol of 70S ribosomes per ml of serum, as determined by turbidity formation [Howard G., Smith RL, Gordon J. ( 1976), J. Mol. Biol. 106, 623-637], diluted in a ratio of 1:10 in saline containing 3% bovine serum albumin and 10% rabbit carrier serum. The sheets are washed in saline (about five changes during 30 minutes, total) and incubated with the second (indicator) antibody directed against the immunogl ⁇ bulins of the first antiserum.
- Horseradish peroxidase-conjugated rabbit anti-goat immuno globulin G (Nordic Laboratories, Tillburg, Netherlands) are reconsti tuted before use according to the manufacture's instructions.
- Horseradish peroxidase-conjugated immunoglobulins preparations are used at 1: 2000 dilution in saline containing 3% bovine serum albumin and 10% rabbit serum. The blots are incubated for 2 hours at room temperature and washed as described above. For the color reaction [based on Avrameas, S. & Guilbert, B. (1971) Eur. J. Immunol. I, 394- 396] the blots are soaked in a solution of 25 micrograms per ml of o-Dianisidine / 0.01% to H 2 O 2/10 mM Tris-HCl, pH 7.4.
- Example 2 The purified proteins L7 / L12 as described in Example 1 are separated by electrophoresis in a gel, corresponding to the second dimension only, of Example 1. The same detection procedure is also used with peroxidase-conjugated rabbit anti-goat immunoglobulin. The amount of protein applied to 1 cm slots in the top of the gel is varied over a wide range. In general, the bands of protein are sharper after only one dimension of electrophoresis, so that the sensitivity of detection is correspondingly higher. There is a significant color reaction with as little as 50 pg of the proteins L7 / L12.
- Example 3 Chicken liver ribosomal subunits are prepared and separated, and the total protein prepared from them, as already described in detail. [Ramjoué, HPR & Gordon, J. (1977), J.Biol. Chem. 252, 9065-9070]. They are tritiated by reductive methylation with formaldehyde and sodium bortritiide [Moore, G. & Crichton, RR (1974), Biochem. J. 143, 604-612]. The radioactive protein is diluted with a suitable amount of nonradioactive carrier protein ⁇ f the same kind, and 35 ⁇ g is applied to duplicate identical gels. They are subjected to two dimensional electrophoresis as described in Example 1.
- One gel is stained directly for 4 hours with Coomassie blue R250 (0.1% in 7.5% acetic acid and 50% methanol) and destained electrophoretically in 7.5% acetic acid, 7.5% methanol .
- the other gel is transferred electrophoretically to nitrocellulose as described in Example 1, stained with amido black for 3 minutes (0.1% in 45% methanol, 10% acetic acid) and destained with 90% methanol, 2% acetic acid. Individual stained spots are cut out and radioactivity determined after combustion in a sample oxidizer (Oxymat, Intertechnique, France) as 3 H 2 O.
- Example 4 Subunits from chick liver ribosomes are prepared as in Example 3, combined in equimolar amounts and used to elicit antibodies in a series of individual mice. Each (BALB / C strain) mouse receives 200 ⁇ g of the preparation emulsified in 125 ⁇ g of Freund's Complete Adjuvant, and injected in one intraperitoneal and four subcutaneous sites.
- Booster injections of 400 ⁇ g of ribosomes in physiological saline are given intraperitoneally on days 33, 57, 58, 59.
- the animals are bled by tail incision on day 71.
- the individual mouse sera are examined for their contents of antibodies against individual ribosomal proteins as follows.
- Total chick liver ribosomal protein prepared as above (400 ⁇ g) is applied as a 14 cm line to the top of a gel slab corresponding to the second dimension of the electrophoresis of Example 1.
- the electropherogram is transferred to a nitrocallulose sheet as in Example 1 , and treated with bovine serum albumin in saline in the same way.
- the sheet is then cut into 5 mm wide strips parallel to the direction of electrophoresis.
- Each strip then contains a representative section of the entire original electropherogram.
- the individual mouse sera are then diluted 50-fold into physiological saline containing 3% bovine serum albumin and 10% non-immune goat serum.
- Each strip of nitrocellulose is incubated for 6 hours at room temperature in 250 ⁇ l of this dilution, and washed in physiological saline as in the first example.
- the second indicator antibody is prepared as follows: hyperimmune sheep anti mouse immtinoglobulin is purified by affinity chromatography on Sepaharose-bound mouse myeloma proteins containing ⁇ , ⁇ ,
- Y 1 , Y 2A , Y 2B , ⁇ and ⁇ chains The iodination is carried out by the chloramine T method [Matsku, I. & Zöller, M. (1977), Immunochemistry 14, 367-371] using 450 ⁇ g of protein and 1.5 mCi of Na 125 I in 0.5 ml for 60 seconds at room temperature. The reaction is stopped with excess sodium metabisulfita and non-radioactive NaI to a final concentration of 10 mM. The excess free iodide is removed on a Sephadex G25 column previqusly saturated with physiological saline and 0.1% bovine serum albumin. The labeled antibody is stored in 0.75% bovine serum albumin.
- the specific activity is c. 1.5 ⁇ Ci / ⁇ g. This is diluted into physiological saline containing 3% bovine serum albumin and 10% normal goat serum, to 10 6 cpm / ml. The nitrocellulose strips are incubated in 250 ⁇ l of this solution for 6 hours at room temperature, washed with 5 changes of physiological saline over 0.5 hour, dried with a hair dryer, and exposed to Kodak X-Omat R film for 6 days. The autoradiogram shows the heterogeneity of the responses of the individual mice to a complex set of immunogens. This procedure is a prototype for the screening of individual sera for the presence of individual antibodies against a complex set of immunogens.
- Example 5 Human serum (1 ⁇ l) is subject to electrophoresis in one dimension according to the widely used method [Laemmli, U.K. (1970), Nature 227, 680-685] with a 15% acrylamide gel.
- the electrophoretic transfer from the gel to a nitrocellulose sheet is in a medium containing 25 mM Tris, 192 mM glycine, 20% methanol, pH 8.3, and the sheet is on the anodal side of the gel.
- the position of the human immunoglobulin G in the nitrocellulose sheet is located as performed in the last step of Example 1, except that peroxidase conjugated rabbit anti-human IgG is used.
- the result shows a band of stain corresponding to the position to be expected from the molecular weight of the IgG fraction in the original electropherogram.
- This shows that the dodecyl sulfate complex of this protein is successfully transferred to the nitrocellulose sheet, and is also still capabla of binding its respective antibody.
- Other similar examples show that with a wide variety of proteins that essentially all get transferred from such gels containing sodium dodecyl sulfate, without loss of resolution or antigenicity, although the efficiency of transfer is not systematically as high as that for gels not containing detergent, such as in Example 3.
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1980/000018 WO1981002790A1 (en) | 1980-03-18 | 1980-03-18 | New solid supports for proteins for analytical purposes |
JP55500788A JPS60501472A (ja) | 1980-03-18 | 1980-03-18 | 分析を目的とする蛋白質の新規固体支持体 |
DE19803050311 DE3050311C2 (de) | 1980-03-18 | 1980-03-18 | Verfahren zur herstellung fester Tr{ger f}r Prote ine zu analytischen Zwecken |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
WOEP80/00018 | 1980-03-18 | ||
PCT/EP1980/000018 WO1981002790A1 (en) | 1980-03-18 | 1980-03-18 | New solid supports for proteins for analytical purposes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1981002790A1 true WO1981002790A1 (en) | 1981-10-01 |
Family
ID=8164803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1980/000018 WO1981002790A1 (en) | 1980-03-18 | 1980-03-18 | New solid supports for proteins for analytical purposes |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS60501472A (enrdf_load_stackoverflow) |
DE (1) | DE3050311C2 (enrdf_load_stackoverflow) |
WO (1) | WO1981002790A1 (enrdf_load_stackoverflow) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534030A1 (fr) * | 1982-10-01 | 1984-04-06 | Pasteur Institut | Procede de detection et de dosage d'une substance biologique par erythroadsorption |
EP0141001A1 (fr) * | 1982-09-27 | 1985-05-15 | SPIRAL Société à responsabilité limitée dite : | Dosage immunologique dans le sérum de l'apolipoprotéine B des lipoprotéines de basse densité |
US4545888A (en) * | 1984-04-06 | 1985-10-08 | Walsh J William | Apparatus for electrophoretic recovery of nucleic acids and other substances |
US4589965A (en) * | 1984-11-14 | 1986-05-20 | International Biotechnologies, Inc. | Method for electroblotting |
FR2574936A1 (fr) * | 1984-12-14 | 1986-06-20 | Biolyon | Anode plate et dispositif pour electrophorese transversale la contenant |
FR2586689A1 (fr) * | 1985-09-02 | 1987-03-06 | Plant Genetic Systems Nv | Moyens et procedes de transfert de proteines sur une surface receptrice supportee |
EP0214909A1 (fr) * | 1985-09-02 | 1987-03-18 | Plant Genetic Systems N.V. | Moyens et procedes de transfert de proteines et/ou d'acides nucleiques sur une surface receptrice supportee |
US4703017A (en) * | 1984-02-14 | 1987-10-27 | Becton Dickinson And Company | Solid phase assay with visual readout |
US4889606A (en) * | 1987-10-20 | 1989-12-26 | Amersham International Plc | Electrophoresis and transfer for |
EP0592026A1 (en) * | 1983-08-17 | 1994-04-13 | Scripps Clinic And Research Foundation | Method for determining antigenic reactivity in urine |
US5602040A (en) * | 1987-04-27 | 1997-02-11 | Unilever Patent Holdings B.V. | Assays |
US5968839A (en) * | 1996-05-13 | 1999-10-19 | Metrika, Inc. | Method and device producing a predetermined distribution of detectable change in assays |
CN1063265C (zh) * | 1996-12-31 | 2001-03-14 | 中国科学院新疆化学研究所 | 电泳转移一种大分子核酸的方法 |
WO2002048712A1 (en) * | 2000-12-13 | 2002-06-20 | The Additional Director (Ipr), Defence Research & Development Organisation | A method of detection of e-coli, other coliforms and pathogenic organisms in water |
US7384796B2 (en) | 1989-02-17 | 2008-06-10 | Inverness Medical Switzerland Gmbh | Assays |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3554894A (en) * | 1968-01-11 | 1971-01-12 | Edward Saul Zemel | Protein quantitation plate for electrophoretic apparatus and method of making and using same |
GB1513169A (en) * | 1974-07-31 | 1978-06-07 | Snam Progetti | Fibres incorporating antibodies antigens and antisera method for their preparation and their use |
WO1979000044A1 (en) * | 1977-07-14 | 1979-02-08 | H Elwing | Method for the determination of biological substances by diffusion in a porous matrix or by electrophoresis |
-
1980
- 1980-03-18 JP JP55500788A patent/JPS60501472A/ja active Granted
- 1980-03-18 WO PCT/EP1980/000018 patent/WO1981002790A1/de active Application Filing
- 1980-03-18 DE DE19803050311 patent/DE3050311C2/de not_active Expired
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3554894A (en) * | 1968-01-11 | 1971-01-12 | Edward Saul Zemel | Protein quantitation plate for electrophoretic apparatus and method of making and using same |
GB1513169A (en) * | 1974-07-31 | 1978-06-07 | Snam Progetti | Fibres incorporating antibodies antigens and antisera method for their preparation and their use |
WO1979000044A1 (en) * | 1977-07-14 | 1979-02-08 | H Elwing | Method for the determination of biological substances by diffusion in a porous matrix or by electrophoresis |
Non-Patent Citations (5)
Title |
---|
Analytical Biochemistry, vol. 46, no. 1, issued 1972, (USA), H. Rainer Maurer et al.: "Polyacrylemide gel electrophoresis on micro slabs", pages 19-32 * |
Chemical Abstracts, vol. 73, no. 22, issued November 30, 1970, (Columbus, Ohio, US), M.D. Gebott et al.: "Polymeric parameters of cellulosis support media affecting serum protein electrophoresis" see page 76, the abstract no. 111102m; & Appl. Polym. Symp. 1969 (Pub. 1970) no. 13, 211-33 (ENG.) * |
Chemical Abstracts, vol. 92, no. 1, issued January 7, 1980, (Columbus, Ohio, US), Takahashi Nobuhiro et al.: "Immunochemical detection of plasma proteins after two-dimensional electrophoresis", see page 276, the abstract no. 2752v; & Seibutsu Butsuri Kagaku 1979, 22(4), 279-84, Japan * |
Chemical Abstracts, vol. 92, no. 19, issued May 12, 1980, (Columbus, Ohio, US), M. Bittner et al.: "Electrophoretic transfer of proteins and nucleic acids from slab gels to diazobenzyloxymethyl cellulose or nitrocellulose sheets", see page 259, the abstract no. 159945h; & Anal. Biochem. 1980, 102(2), 459-71 * |
Proceedings of the National Academy of Science, vol. 76, no. 9, issued September 1979, (USA), Harry Towbin et al.: "Electrophoretic transfer of proteins from polyacrylemide gels to nitrocellulose sheets: Procedure and some applications", pages 4350 to 4354 * |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0141001A1 (fr) * | 1982-09-27 | 1985-05-15 | SPIRAL Société à responsabilité limitée dite : | Dosage immunologique dans le sérum de l'apolipoprotéine B des lipoprotéines de basse densité |
US4668637A (en) * | 1982-10-01 | 1987-05-26 | Institut Pasteur | Method for detecting and dosing by erythroadsorption a biological substance |
WO1984001436A1 (fr) * | 1982-10-01 | 1984-04-12 | Pasteur Institut | Procede de detection et de dosage d'une substance biologique par erythroadsorption |
EP0107551A1 (fr) * | 1982-10-01 | 1984-05-02 | Institut Pasteur | Procédé de détection et de dosage d'une substance biologique par érythroadsorption |
FR2534030A1 (fr) * | 1982-10-01 | 1984-04-06 | Pasteur Institut | Procede de detection et de dosage d'une substance biologique par erythroadsorption |
EP0592026A1 (en) * | 1983-08-17 | 1994-04-13 | Scripps Clinic And Research Foundation | Method for determining antigenic reactivity in urine |
US4703017A (en) * | 1984-02-14 | 1987-10-27 | Becton Dickinson And Company | Solid phase assay with visual readout |
US4545888A (en) * | 1984-04-06 | 1985-10-08 | Walsh J William | Apparatus for electrophoretic recovery of nucleic acids and other substances |
US4589965A (en) * | 1984-11-14 | 1986-05-20 | International Biotechnologies, Inc. | Method for electroblotting |
EP0186577A3 (fr) * | 1984-12-14 | 1989-01-18 | BIOLYON Société Anonyme dite: | Dispositif pour électrophorèse transversale |
FR2574936A1 (fr) * | 1984-12-14 | 1986-06-20 | Biolyon | Anode plate et dispositif pour electrophorese transversale la contenant |
US4839231A (en) * | 1985-01-10 | 1989-06-13 | Plant Genetic Systems N.V. | Agents and procedures for the transfer of proteins and/or nucleic acids onto a supported receptor surface |
FR2586689A1 (fr) * | 1985-09-02 | 1987-03-06 | Plant Genetic Systems Nv | Moyens et procedes de transfert de proteines sur une surface receptrice supportee |
EP0214909A1 (fr) * | 1985-09-02 | 1987-03-18 | Plant Genetic Systems N.V. | Moyens et procedes de transfert de proteines et/ou d'acides nucleiques sur une surface receptrice supportee |
US5602040A (en) * | 1987-04-27 | 1997-02-11 | Unilever Patent Holdings B.V. | Assays |
US7109042B2 (en) | 1987-04-27 | 2006-09-19 | Inverness Medical Switzerland Gmbh | Assays |
US4889606A (en) * | 1987-10-20 | 1989-12-26 | Amersham International Plc | Electrophoresis and transfer for |
EP0313293A3 (en) * | 1987-10-20 | 1991-04-03 | AMERSHAM INTERNATIONAL plc | Method and apparatus for use in biological testing |
US7384796B2 (en) | 1989-02-17 | 2008-06-10 | Inverness Medical Switzerland Gmbh | Assays |
US7407813B2 (en) | 1989-02-17 | 2008-08-05 | Inverness Medical Switzerland Gmbh | Assays |
US5968839A (en) * | 1996-05-13 | 1999-10-19 | Metrika, Inc. | Method and device producing a predetermined distribution of detectable change in assays |
CN1063265C (zh) * | 1996-12-31 | 2001-03-14 | 中国科学院新疆化学研究所 | 电泳转移一种大分子核酸的方法 |
WO2002048712A1 (en) * | 2000-12-13 | 2002-06-20 | The Additional Director (Ipr), Defence Research & Development Organisation | A method of detection of e-coli, other coliforms and pathogenic organisms in water |
Also Published As
Publication number | Publication date |
---|---|
JPS6244612B2 (enrdf_load_stackoverflow) | 1987-09-21 |
JPS60501472A (ja) | 1985-09-05 |
DE3050311T1 (enrdf_load_stackoverflow) | 1982-04-15 |
DE3050311C2 (de) | 1987-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4452901A (en) | Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays | |
Towbin et al. | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. | |
Anderson et al. | Specific antiserum staining of two‐dimensional electrophoretic patterns of human plasma proteins immobilized on nitrocellulose | |
WO1981002790A1 (en) | New solid supports for proteins for analytical purposes | |
Yagi et al. | Immunoelectrophoretic identification of guinea pig anti-insulin antibodies | |
Koshland et al. | Differences in the amino acid composition of two purified antibodies from the same rabbit | |
Keck et al. | Specific characterization of isoelectrofocused immunoglobulins in polyacrylamide gel by reaction with 125I‐labeled protein antigens or antibodies | |
Fischer‐Colbrie et al. | Isolation and immunological characterization of a glycoprotein from adrenal chromaffin granules | |
Ranney et al. | Haemoglobin New York | |
US4279884A (en) | Process for preparation of antisera | |
Schmidt-Ullrich et al. | Concanavalin A-reactive protein of rabbit thymocyte plasma membranes: analysis by crossed immune electrophoresis and sodium dodecylsulfate/polyacrylamide gel electrophoresis | |
Svenson et al. | An enzyme-linked immunosorbent assay (ELISA) for the determination of diphtheria toxin antibodies | |
Keck et al. | Antibodies of restricted heterogeneity induced by DNP-insulin | |
Marashi et al. | Purification and partial characterization of nucleolar antigen-1 of the Novikoff hepatoma | |
Aubertin et al. | Sodium dodecyl sulfate-mediated transfer of electrophoretically separated DNA-binding proteins | |
Anderton et al. | New methods of analysing for antigens and glycoproteins in complex mixtures | |
Syu et al. | Use of protein-stained immunoblots for unequivocal identification of antibody specificities | |
JPH06100604B2 (ja) | α−フェトプロテインの分画検出試薬キットおよび分画検出方法 | |
Allen | The N-terminal amino acid of an avian leukosis group-specific antigen from avian myeloblastosis virus | |
Lorenzi et al. | On the macromolecular composition of the jelly coat from Strongylocentrotus purpuratus eggs | |
Boulay et al. | Localization of immunoreactive regions in the beef heart adenine nucleotide carrier using rabbit antisera against the carboxyatractyloside-liganded and the sodium dodecyl sulfate denatured carrier forms | |
Peltier et al. | Ribonucleoprotein (RNP) soluble nuclear antigen: demonstration of its reaction with serum antibodies by counter-immunoelectrophoresis and further partial characterization | |
Smith et al. | Immunological properties of membrane fractions from wild type and dnaA mutants of Escherichia coli | |
JPS63500207A (ja) | 新規な分子量標準とその使用方法 | |
Knisley et al. | Isoelectric focusing analysis of antibody clonotype changes occurring during immune responses using immobilized pH gradients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): DE JP US |
|
RET | De translation (de og part 6b) |
Ref document number: 3050311 Country of ref document: DE Date of ref document: 19820415 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3050311 Country of ref document: DE |